Bellwether Investment Group LLC reduced its position in shares of Medtronic plc. (NYSE:MDT) by 6.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,686 shares of the medical technology company’s stock after selling 123 shares during the period. Bellwether Investment Group LLC’s holdings in Medtronic plc. were worth $136,000 as of its most recent filing with the SEC.

Other large investors have also recently modified their holdings of the company. Jackson Grant Investment Advisers Inc. increased its position in shares of Medtronic plc. by 0.3% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 2,920 shares of the medical technology company’s stock worth $235,000 after buying an additional 9 shares during the last quarter. Hudock Capital Group LLC increased its position in shares of Medtronic plc. by 0.6% in the first quarter. Hudock Capital Group LLC now owns 2,184 shares of the medical technology company’s stock worth $175,000 after buying an additional 12 shares during the last quarter. Delta Asset Management LLC TN increased its position in shares of Medtronic plc. by 0.4% in the first quarter. Delta Asset Management LLC TN now owns 3,713 shares of the medical technology company’s stock worth $299,000 after buying an additional 13 shares during the last quarter. Tarbox Group Inc. increased its position in shares of Medtronic plc. by 0.4% in the first quarter. Tarbox Group Inc. now owns 5,180 shares of the medical technology company’s stock worth $417,000 after buying an additional 20 shares during the last quarter. Finally, Shufro Rose & Co. LLC increased its position in shares of Medtronic plc. by 0.3% in the first quarter. Shufro Rose & Co. LLC now owns 10,381 shares of the medical technology company’s stock worth $836,000 after buying an additional 28 shares during the last quarter. Institutional investors and hedge funds own 80.49% of the company’s stock.

Shares of Medtronic plc. (NYSE MDT) traded up 0.357% during mid-day trading on Thursday, hitting $80.145. The stock had a trading volume of 2,180,724 shares. The firm’s 50-day moving average price is $84.48 and its 200 day moving average price is $83.39. The stock has a market cap of $109.15 billion, a price-to-earnings ratio of 26.976 and a beta of 1.02. Medtronic plc. has a 12-month low of $69.35 and a 12-month high of $89.72.

Medtronic plc. (NYSE:MDT) last posted its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.08 by $0.04. The business had revenue of $7.39 billion during the quarter, compared to the consensus estimate of $7.44 billion. Medtronic plc. had a return on equity of 12.92% and a net margin of 13.75%. Medtronic plc.’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.03 earnings per share. Equities analysts forecast that Medtronic plc. will post $4.76 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 20th. Investors of record on Friday, September 29th will be issued a $0.46 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.84 dividend on an annualized basis and a yield of 2.30%. Medtronic plc.’s payout ratio is 61.95%.

TRADEMARK VIOLATION NOTICE: “Medtronic plc. (MDT) Shares Sold by Bellwether Investment Group LLC” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.watchlistnews.com/medtronic-plc-mdt-shares-sold-by-bellwether-investment-group-llc/1534428.html.

A number of brokerages recently commented on MDT. William Blair restated an “outperform” rating on shares of Medtronic plc. in a research note on Thursday, July 6th. BidaskClub upgraded Medtronic plc. from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 17th. Wells Fargo & Company restated an “outperform” rating on shares of Medtronic plc. in a research note on Wednesday, July 12th. Oppenheimer Holdings, Inc. restated a “buy” rating on shares of Medtronic plc. in a research note on Tuesday, July 18th. Finally, Needham & Company LLC restated a “buy” rating and set a $95.00 price objective (up from $91.00) on shares of Medtronic plc. in a research note on Thursday, May 25th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $88.78.

In related news, EVP Bryan C. Hanson sold 12,000 shares of the stock in a transaction on Monday, July 17th. The stock was sold at an average price of $88.57, for a total value of $1,062,840.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard H. Anderson acquired 5,600 shares of the firm’s stock in a transaction that occurred on Wednesday, June 21st. The stock was bought at an average price of $88.90 per share, with a total value of $497,840.00. Following the completion of the acquisition, the director now directly owns 71,910 shares of the company’s stock, valued at $6,392,799. The disclosure for this purchase can be found here. Corporate insiders own 0.25% of the company’s stock.

About Medtronic plc.

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Institutional Ownership by Quarter for Medtronic plc. (NYSE:MDT)

Receive News & Ratings for Medtronic plc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic plc. and related companies with Analyst Ratings Network's FREE daily email newsletter.